Bacteriophage Therapy of Mycobacterium abscessus Mastoiditis
Open Access
- 15 July 2026
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 83 (5) , e1027-e1031
Abstract
We describe a case of a child with macrolide-resistant Mycobacterium abscessus who initially had clinical improvement on a dual β-lactam regimen but continued to have positive cultures. Suitable phages active against the bacterial strain were identified, administered both systemically and directly to the ear, and were associated with microbiological remission.Keywords
Funding Information
- Norges Idrettshøgskole (GM131729)
- Howard Hughes Medical Institute (GT12053)
- Cystic Fibrosis Foundation (Hatfull19GO)
- Cystic Fibrosis Foundation (Hatfull21GO)
- Emily’s Entourage
This publication has 17 references indexed in Scilit:
- Successful treatment of macrolide-resistant Mycobacterium abscessus infection using multi-drug regimens including dual β-lactams and phage therapy: case reports in two childrenASM Case Reports, 2025
- Mycobacterium abscessus group pulmonary diseaseCurrent Opinion in Infectious Diseases, 2025
- Interactive Tree of Life (iTOL) v6: recent updates to the phylogenetic tree display and annotation toolNucleic Acids Research, 2024
- Therapeutically useful mycobacteriophages BPs and Muddy require trehalose polyphleatesNature Microbiology, 2023
- Phage Therapy of Mycobacterium Infections: Compassionate Use of Phages in 20 Patients With Drug-Resistant Mycobacterial DiseaseClinical Infectious Diseases, 2022
- Quality of life in children receiving treatment for Mycobacterium abscessus otomastoiditisClinical Otolaryngology, 2022
- Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice GuidelineClinical Infectious Diseases, 2020
- IQ-TREE 2: New Models and Efficient Methods for Phylogenetic Inference in the Genomic EraMolecular Biology and Evolution, 2020
- Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessusNature Medicine, 2019
- Mycobacterium abscessus: a new antibiotic nightmareJournal of Antimicrobial Chemotherapy, 2012